Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T‐cell migration

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Immunology

• Publication date

  2003-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2567.2003.01562.xPMID 12519300PMCID PMC1782871
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-12, STAT4-Dependent Up-Regulation of CD4+ T Cell Core 2 β-1,6-n-Acetylglucosaminyltransferase, an Enzyme Essential for Biosynthesis of P-Selectin Ligands1

  2001cited by this paper
• Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow

  2001cited by this paper
• Overexpression of MUC1 reconfigures the binding properties of tumor cells

  2001cited by this paper
• Identification of three non‐VNTR MUC1‐derived HLA‐A*0201‐restricted T‐cell epitopes that induce protective anti‐tumor immunity in HLA‐A2/Kb‐transgenic mice

  2001cited by this paper
• Three Different Vaccines Based on the 140-Amino Acid MUC1 Peptide with Seven Tandemly Repeated Tumor-Specific Epitopes Elicit Distinct Immune Effector Mechanisms in Wild-Type Versus MUC1-Transgenic Mice with Different Potential for Tumor Rejection1

  2001cited by this paper
• IL-2, -4, and -15 Differentially Regulate O-Glycan Branching and P-Selectin Ligand Formation in Activated CD8 T Cells1

  2001cited by this paper
• Novel breast‐tumor‐associated MUC1‐derived peptides: Characterization in Db−/− × β2 microglobulin (β2m) null mice transgenic for a chimeric HLA‐A2.1/Db‐β2 microglobulin single chain

  2000cited by this paper
• Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction.

  2000cited by this paper
• Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain.

  2000cited by this paper
• Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.

  2000cited by this paper
• MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines

  2000cited by this paper
• Long term survival of patients with advanced ovarian cancer treated with intraperitoneal radioimmunotherapy.

  2000cited by this paper
• The epithelial mucin, MUC1, is expressed on resting T lymphocytes and can function as a negative regulator of T cell activation.

  2000cited by this paper
• Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells.

  2000cited by this paper
• Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma.

  2000cited by this paper
• Leukocyte polarization in cell migration and immune interactions

  1999cited by this paper
• Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.

  1999cited by this paper
• Lack of evidence for an immunosuppressive role for MUC1

  1999cited by this paper
• Soluble MUC1 secreted by human epithelial cancer cells mediates immune suppression by blocking T‐cell activation

  1999cited by this paper
• Control of O-Glycan Branch Formation

  1999cited by this paper
• Control of O-Glycan Branch Formation

  1999cited by this paper
• Tyrosine replacement in P-selectin glycoprotein ligand-1 affects distinct kinetic and mechanical properties of bonds with P- and L-selectin.

  1999cited by this paper
• Macrophage–tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter‐receptor for the macrophage‐restricted receptor, sialoadhesin

  1999cited by this paper
• Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines.

  1998cited by this paper
• Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2

  1998cited by this paper
• CD4+ lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic mice.

  1998cited by this paper
• Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation.

  1998cited by this paper
• Monoclonal Antibodies against the Nonmucin Domain of MUC1/Episialin

  1997cited by this paper
• Reactivity of Antibodies with Highly Glycosylated MUC1 Mucins from Colon Carcinoma Cells and Bile

  1997cited by this paper
• ICAMs Redistributed by Chemokines to Cellular Uropods as a Mechanism for Recruitment of T Lymphocytes

  1997cited by this paper
• Epitope Characterization of MUC1 Antibodies

  1997cited by this paper
• A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1.

  1996cited by this paper
• Regulation of adhesion molecule expression by human synovial microvascular endothelial cells in vitro.

  1996cited by this paper
• Comparison of O-Linked Carbohydrate Chains in MUC-1 Mucin from Normal Breast Epithelial Cell Lines and Breast Carcinoma Cell Lines:

  1996cited by this paper
• Role of E Box and Initiator Region in the Expression of the Rat Follicle-stimulating Hormone Receptor*

  1996cited by this paper
• Intramuscular immunisation with MUC1 cDNA can protect C57 mice challenged with MUC1‐expressing syngeneic mouse tumour cells

  1996cited by this paper
• Enrichment of differentiated CD45RBdim,CD27- memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis.

  1996cited by this paper
• Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin.

  1995cited by this paper
• MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer Vaccines

  1995cited by this paper
• Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components

  1995cited by this paper
• Does pregnancy immunize against breast cancer?

  1995cited by this paper
• Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.

  1994cited by this paper
• Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product.

  1993cited by this paper
• Expression of the developmental I antigen by a cloned human cDNA encoding a member of a beta-1,6-N-acetylglucosaminyltransferase gene family.

  1993cited by this paper
• Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction.

  1993cited by this paper
• Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice.

  1992cited by this paper
• Epitope mapping of anti-breast and anti-ovarian mucin monoclonal antibodies.

  1992cited by this paper
• Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen.

  1992cited by this paper
• Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.

  1991cited by this paper
• Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin.

  1990cited by this paper
• Structures of neutral O-linked polylactosaminoglycans on human skim milk mucins. A novel type of linearly extended poly-N-acetyllactosamine backbones with Gal beta(1-4)GlcNAc beta(1-6) repeating units.

  1989cited by this paper
• A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM‐3 is selectively exposed in a range of primary carcinomas

  1989cited by this paper
• Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line.

  1989cited by this paper
• Tissue and tumor distribution of human polymorphic epithelial mucin

  1988cited by this paper

• The landscape of research on B cell and immunotherapy in solid tumors over the past 20 years

  2025cites this paper
• Identifying the potential origin of mucin in primary cutaneous mucinoses—A retrospective study and analysis using histopathology and multiplex fluorescence staining

  2023cites this paper
• Glycocalyx dynamics and membrane curvature under cytosolic pressure

  2023cites this paper
• Mammalian Neuraminidases in Immune-Mediated Diseases: Mucins and Beyond

  2022cites this paper
• Chemoradiation-induced alteration of programmed death-ligand 1, CD8+ tumor-infiltrating lymphocytes and mucin expression in rectal cancer

  2022cites this paper
• Biology, Significance and Immune Signaling of Mucin 1 in Hepatocellular Carcinoma.

  2022cites this paper
• A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severity

  2021cites this paper
• Gene Expression and Resistance to Glucocorticoid-Induced Apoptosis in Acute Lymphoblastic Leukemia: A Brief Review and Update.

  2020cites this paper
• Magnetic Particles for CTC Enrichment

  2020cites this paper
• MUC1 in Cancer Immunotherapy — New Hope or Phantom Menace?

  2019cites this paper
• Immunohistochemical profiling of mucins in sinonasal adenocarcinomas.

  2019cites this paper
• A Purified Aspartic Protease from Akkermansia Muciniphila Plays an Important Role in Degrading Muc2

  2019cites this paper
• Modulating MUC1 Function on T Cells.

  2019cites this paper
• Mucins and Pathogenic Mucin-Like Molecules Are Immunomodulators During Infection and Targets for Diagnostics and Vaccines

  2019cites this paper
• MUC1 and Cancer Immunotherapy

  2018cites this paper
• Chimeric antigen receptor (CAR) T-cell immunotherapy for MUC1-positive breast cancer

  2018cites this paper
• Latest developments in MUC1 immunotherapy

  2018cites this paper
• MUC1 Mucin: A Putative Regulatory (Checkpoint) Molecule of T Cells

  2018influential citation
• Identification of novel glycosylation patterns in cancer and their role in cancer progression and metastasis

  2018cites this paper
• Muc1 knockout potentiates murine lung carcinogenesis involving an epiregulin-mediated EGFR activation feedback loop

  2017cites this paper
• Novel Regulatory Mechanisms and Functions of MUC4 in Pancreatic Cancer

  2016cites this paper
• MUC1 (CD227): a multi-tasked molecule

  2015cites this paper
• MUC1 in macrophage: contributions to cigarette smoke-induced lung cancer.

  2014cites this paper
• Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis.

  2014cites this paper
• Lung Cancer Induced − MUC 1 in Macrophage : Contributions to Cigarette Smoke

  2014cites this paper
• Modulation of glycan recognition by clustered saccharide patches.

  2014cites this paper
• Mechanisms of antitumor and immune-enhancing activities of MUC1/sec, a secreted form of mucin-1

  2013cites this paper
• Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms

  2013cites this paper
• Investigating breast cancer O-linked glycosylation changes and their immunotherapeutic potential

  2013cites this paper
• MUC1 is a novel costimulatory molecule of human T cells and functions in an AP-1-dependent manner.

  2012cites this paper
• MUC2 polymorphisms are associated with endometriosis development and infertility: a case-control study

  2012cites this paper
• MUC 2 polymorphisms are associated with endometriosis development and infertility : a case-control study

  2012cites this paper
• Mucin from rheumatoid arthritis synovial fluid enhances interleukin-6 production by human peripheral blood mononuclear cells.

  2011cites this paper
• Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.

  2011influential citation
• Aberrant overexpression of membrane-associated mucin contributes to tumor progression in adult T-cell leukemia/lymphoma cells

  2011cites this paper
• DNA methylation and histone H3-K9 modifications contribute to MUC17 expression.

  2011cites this paper
• DNA methylation and histone H 3K 9 modi fi cations contribute to MUC 17 expression

  2010cites this paper
• MUC1 immunotherapy.

  2010cites this paper
• Circulating tumour cells in cancer patients: challenges and perspectives.

  2010cites this paper
• Biosynthesis of Complex Mucin-Type O -Glycans

  2010cites this paper
• Surface Mucin-1 does not play a role in dendritic cell migration.

  2009cites this paper
• Immunity and tolerance to the tumor-associated antigen MUC1

  2009cites this paper
• Expression of mucin 3 and mucin 5AC in arthritic synovial tissue.

  2008cites this paper
• Advances of MUC1 as a target for breast cancer immunotherapy.

  2007influential citation
• The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma

  2007cites this paper
• The Mouse Trap: How Well Do Mice Model Human Immunology?

  2007cites this paper
• MUC 1 Oncoprotein Regulates Bcr-Abl Stability and Pathogenesis in Chronic Myelogenous Leukemia Cells

  2007cites this paper
• MUC1 oncoprotein regulates Bcr-Abl stability and pathogenesis in chronic myelogenous leukemia cells.

  2007cites this paper
• Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways.

  2007cites this paper
• MUC1 is involved in trophoblast transendothelial migration.

  2007cites this paper
• Increased Production of the Soluble Tumor‐Associated Antigens CA19‐9, CA125, and CA15‐3 in Rheumatoid Arthritis

  2007cites this paper
• MUC1 in the relationship between inflammation and cancer in IBD

  2006cites this paper
• PankoMab: a potent new generation anti-tumour MUC1 antibody

  2006cites this paper
• Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients.

  2005cites this paper
• Recombinant Tumor-Associated MUC1 Glycoprotein Impairs the Differentiation and Function of Dendritic Cells1

  2005cites this paper
• DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD

  2005cites this paper
• Dendritic Cells Induce MUC1 Expression and Polarization on Human T Cells by an IL-7-Dependent Mechanism1

  2005cites this paper
• MUC1 as a target antigen for cancer immunotherapy

  2005cites this paper
• Mammary Ducts With and Without Focal Myoepithelial Cell Layer Disruptions Show a Different Frequency of White Blood Cell Infiltration and Growth Pattern: Implications for Tumor Progression and Invasion

  2005cites this paper
• Responses of human T cells to peptides flanking the tandem repeat and overlapping the signal sequence of MUC1

  2005cites this paper
• MUC1 mucin-mediated regulation of human T cells.

  2005cites this paper
• MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells

  2005cites this paper
• Human Tumor Antigen MUC1 as an Inducer of Dendritic Cell Migration and Distorted Maturation

  2005influential citation
• MUC1 Mediates Transendothelial Migration in vitro by Ligating Endothelial Cell ICAM-1

  2005cites this paper
• IL-7-Dependent Mechanism Polarization on Human T Cells by an Dendritic Cells Induce MUC 1 Expression and

  2005cites this paper
• Function of Dendritic Cells Glycoprotein Impairs the Differentiation and Recombinant Tumor-Associated MUC 1

  2005cites this paper
• Mucin-1 is expressed on dendritic cells, both in vitro and in vivo.

  2004cites this paper
• Bioprocess Development for the Generation of Monocyte-derived Dendritic Cells

  2004cites this paper
• Glycosynapses: microdomains controlling carbohydrate-dependent cell adhesion and signaling.

  2004cites this paper
• Altered Immune System Glycosylation Causes Colitis in &agr;1,2-Fucosyltransferase Transgenic Mice

  2004cites this paper
• This information is current as Mouse and Human Immunology Of Mice and Not Men : Differences between

  2004cites this paper
• MUC1 immunobiology: from discovery to clinical applications.

  2004cites this paper
• A Unique Mucin Immunoenhancing Peptide with Antitumor Properties

  2004cites this paper
• Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice.

  2004cites this paper
• Mucins in cancer: protection and control of the cell surface

  2004cites this paper
• Of Mice and Not Men: Differences between Mouse and Human Immunology

  2004cites this paper
• Inhibition of MUC4 Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis

  2004cites this paper
• Breast carcinoma cell lysate-pulsed dendritic cells cross-prime MUC1-specific CD8+ T cells identified by peptide-MHC-class-I tetramers.

  2004cites this paper
• Recombinant MUC 1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells

  2003cites this paper
• DE NOVO EXPRESSION AND FUNCTION OF THE EPITHELIAL MUCIN MUC1 ON T CELLS

  2003influential citation
• Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells.

  2003cites this paper
• The role of B lymphocytes in breast cancer: a review and current status

  2003cites this paper
• Special Topic: Fighting Cancer with Armed T Cells Phase 1 Clinical Trial Demonstrated That Muc1 Positive Metastatic Seminal Vesicle Cancer Can Be Effectively Eradicated by Modified Anti-muc1 Chimeric Antigen Receptor Transduced T Cells

  year unknowncites this paper